Menu Search

Switzerland

SPI Large Company IndexLast 5 days
Last price18,379.33
SPI Medium Company IndexLast 5 days
Last price24,722.81
SPI Small Company IndexLast 5 days
Last price32,241.05
Swiss All-Share IndexLast 5 days
Last price825.73
SMILast 5 days
Last price13,341.27

Loading...

CHF overview

PairLatest rateToday's change1 year change
CHFGBP0.9437
GBP		0.0028 / 0.30%0.0422 / 4.68%
Today
0.8958Jun 06 20250.9713Mar 02 2026
CHFEUR1.09
EUR		0.0022 / 0.20%0.0206 / 1.92%
Today
1.06Aug 18 20251.11Mar 09 2026
CHFUSD1.27
USD		0.004 / 0.32%0.0445 / 3.65%
Today
1.21Jun 04 20251.31Jan 27 2026
CHFJPY202.70
JPY		0.635 / 0.31%28.25 / 16.19%
Today
173.95Jun 05 2025204.42Apr 21 2026
CHFAUD1.78
AUD		0.0041 / 0.23%-0.1073 / -5.70%
Today
1.76May 13 20261.97Oct 17 2025
CHFCAD1.76
CAD		0.0067 / 0.38%0.0898 / 5.37%
Today
1.66Jun 06 20251.79Jan 27 2026
CHFCNY8.58
CNY		0.0321 / 0.38%-0.2017 / -2.30%
Today
8.54Jun 03 20269.14Jan 27 2026

Equity fund country flows

This chart shows the cumulative weekly equity in country flows into or out of Switzerland in USD. EPFR Global provides global coverage of foreign investor flows, tracking over 15,000 funds domiciled around the world.
As of May 19 2021.

Market movers

Constituents of the SMI with the highest percent gain over one day.
ListingLastChangeVolume
Santhera Pharmaceuticals Holding AGSANN:SWX17.70
CHF		+2.48
+16.29%		203.43k
Idorsia LtdIDIA:SWX4.45
CHF		+0.396
+9.77%		1.67m
Kuros Biosciences AGKURN:SWX20.50
CHF		+1.64
+8.70%		250.77k
Centiel AGCNTL:SWX5.76
CHF		+0.36
+6.67%		185.31k
Newron Pharmaceuticals SpANWRN:SWX12.76
CHF		+0.64
+5.28%		89.42k
MCH Group AGMCHN:SWX4.65
CHF		+0.19
+4.26%		19.80k
Tecan Group AGTECN:SWX163.50
CHF		+6.60
+4.21%		52.30k
Roche Holding AGROP:SWX324.60
CHF		+13.00
+4.17%		1.48m
SKAN Group AGSKAN:SWX52.50
CHF		+2.00
+3.96%		32.75k
Roche Holding AGRO:SWX330.80
CHF		+12.60
+3.96%		18.94k
Data delayed at least 15 minutes, as of Jun 04 2026 16:39 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.